Is Evaxion A/S halal to invest in?

According to Musaffa's Shariah screening methodology, Evaxion A/S (EVAX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Evaxion A/S a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Evaxion A/S using these criteria to determine its compliance status.

Can Muslims buy shares of Evaxion A/S?

Muslim investors may consider investing in Evaxion A/S if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Evaxion A/S classified as NOT HALAL?

Musaffa determines the Shariah status of Evaxion A/S by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Evaxion A/S updated?

The Shariah compliance status of Evaxion A/S may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Evaxion A/S become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Evaxion A/S?

You can check the latest Shariah compliance status of Evaxion A/S on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

EVAX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 30, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Evaxion A/S (EVAX)

Based on 10 analysts giving stock ratings to Evaxion A/S in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Evaxion A/S. Stock Analysis EVAX

United States Health Care Nano Cap Report: 2025 Annual

Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Key Statistics of Evaxion A/S (EVAX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$3.91$4.14

Today's Open

$4.14

Volume

26.23K

P/E Ratio (TTM)

52 Week Range

$1.57$12.15

Market Cap

38.11M

Avg. Volume

35.17K

Dividend Yield

Financial Metrics & Statements of Evaxion A/S (EVAX)

FAQ's for Evaxion A/S (EVAX)

According to Musaffa’s Shariah screening methodology, Evaxion A/S (EVAX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.